PDCD1

protein-coding

programmed cell death 1, the group of V-set domain containing|CD molecules

Gene summary

Programmed cell death protein 1 (PDCD1) is an immune-inhibitory receptor expressed in activated T cells; it is involved in the regulation of T-cell functions, including those of effector CD8+ T cells. In addition, this protein can also promote the differentiation of CD4+ T cells into T regulatory cells. PDCD1 is expressed in many types of tumors including melanomas, and has demonstrated to play a role in anti-tumor immunity. Moreover, this protein has been shown to be involved in safeguarding against autoimmunity, however, it can also contribute to the inhibition of effective anti-tumor and anti-microbial immunity. [provided by RefSeq, Aug 2020]

Previous symbols:
  • SLEB2

MANE transcript

NM_005018.3

Inheritance

AR

ClinVar variants

U:15B:6

Top phenotype

Autoimmune disease with susceptibility to mycobacterium tuberculosis

gnomAD constraint

pLI —, LoF o/e 0.21

Max pathogenic AF

—

Genomic locus

chr2:241,849,884-241,858,894

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~9.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

systemic lupus erythematosusSUPPORTIVE

Inheritance Pattern: Unknown

Disease ID:MONDO:0007915

Submitter: Orphanet

autoimmune diseaseLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0007179

Submitter: ClinGen

The *PDCD1* gene codes programmed cell death protein (PD-1), which is an immune-inhibitory receptor expressed in activated T cells. The PD1 protein is involved in the regulation of T-cell functions and the differentiation of CD4+ T cells into T regulatory cells. In 2021, Ogishi et al identified a homozygous frameshift variant of *PDCD1* c.105dup (p.Thr36HisfsTer) in a child born to consanguineous Turkish parents. The patient suffered from extrapulmonary tuberculosis and autoimmune manifestations including hypothyroidism, diabetes and juvenile idiopathic arthritis with autoimmune antibody positivity. The patient’s leukocytes did not express PD-1 and showed impaired production of IFN-γ and TNF upon mycobacterial stimulation, a similarity to inborn errors of IFN-γ production (PMID: 34183838). In addition to the expression evidence, several animal models recapitulated the phenotype observed in the reported proband and exhibited various degrees of lympho-proliferation and autoimmune disease (PMIDs: 10485649,12847137, 20410257, 27410049). Programmed death-1 (PD-1)-deficient mice showed sensitivity to tuberculosis demonstrated by increased bacterial loads and extensive focal necrotic areas after H37Rv aerosol infection, compared with wild-type mice (PMID: 20624978). It is worth mentioning that PD-1 and its ligand PD-L1, are used as drug targets to develop immune checkpoint blockade therapies for cancer. A series of immune-related adverse events (irAEs) which mimic the autoimmune phenotype reported are induced (PMIDs: 26176400, 35991054 , 37715029). Vulnerability to TB are also reported in cancer patients and macaques on PD-1 blockade (PMIDs: 30651320, 33452107). While there is multiple lines of evidence that fulfilled the experimental maximum score of 6 points, the genetic evidence stood at 2 points because there is a single proband reported at the time of this curation. Therefore, the evidence to support this gene-disease relationship is limited. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship.

autoimmune disease with susceptibility to mycobacterium tuberculosisLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0975847

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Autoimmune disease with susceptibility to mycobacterium tuberculosisAR

Manifestation: Allergy/Immunology/Infectious

Intervention: Allergy/Immunology/Infectious

Rationale: The condition can involve susceptibility to mycobacterium tuberculosis, and awareness may enaable preventative measures and early and aggressive treatments of infections, as well as care related to autoimmune manifestations

Refs: 34183838Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to PDCD1 variants in ClinVar

4 Conditions Cataloged
not specifiedTotal: 15
PDCD1-related disorderTotal: 5
not providedTotal: 4
RECLASSIFIED - PDCD1 POLYMORPHISMTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005018.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
1
clinvar
4
missense
14
clinvar
2
clinvar
16
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total00155121
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 13 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005018.3RefSeqNP_005009.25MANE Select
ENST00000334409.10EnsemblENSP00000335062.55MANE Select
ENST00000343705.3EnsemblENSP00000340808.33Standard
ENST00000343705.4EnsemblENSP00000340808.44Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Cell adhesion molecules (CAMs) - Homo sapiens (human)
  • T cell receptor signaling pathway - Homo sapiens (human)
  • T-Cell Receptor and Co-stimulatory Signaling
  • T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection
  • PD-1 signaling

Biological Process

  • negative regulation of tolerance induction
  • apoptotic process
  • humoral immune response
  • multicellular organism development
  • T cell costimulation

Molecular Function

  • protein binding

Cellular Component

  • plasma membrane
  • external side of plasma membrane
  • integral component of membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000334409
Coding exons
5
Length
9028
Individuals with no LoFs
0
Homozygous LoFs
0
Heterozygous LoFs
0
Defined
0
p
0.00
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.291391890.7350.00001271823
Missense (PolyPhen)2552.2050.47889581
Synonymous0.6707582.80.9060.00000592619
Loss of Function2.2629.510.2104.10e-792

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)00.0absent
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Inhibitory cell surface receptor involved in the regulation of T-cell function during immunity and tolerance. Upon ligand binding, inhibits T-cell effector functions in an antigen- specific manner. Possible cell death inducer, in association with other factors. {ECO:0000269|PubMed:21276005}.;
Disease
DISEASE: Systemic lupus erythematosus 2 (SLEB2) [MIM:605218]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:12402038}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.278

Intolerance Scores

LoFtool
0.458
RVIS EVS
-0.31
RVIS percentile EVS
31.93

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.456

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.